Biomarker and updated clinical data for RP1 plus nivolumab in anti–PD-1–failed melanoma from the IGNYTE trial demonstrate reversal of mechanisms of resistance to immune checkpoint blockade
EJC Skin Cancer · 2026 · 4 · 100800
DOI: 10.1016/j.ejcskn.2026.100800 ↗Kurz gefasst
Fachartikel in der Zeitschrift EJC Skin Cancer, 2026. Verfasst von C. Robert und 21 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Robert, C., Bommareddy, P., Wise-Draper, T., Sacco, J., In, G., Couselo, E. M., Schadendorf, D., Niu, J., Beasley, G., Chmielowski, B., Milhem, M., Bowles, T., Tsai, K., Lebbé, C., Gaudy-Marqueste, C., Samson, A., Zhu, J., Viana, M., Tucci, C., …, & Wong, M. (2026). Biomarker and updated clinical data for RP1 plus nivolumab in anti–PD-1–failed melanoma from the IGNYTE trial demonstrate reversal of mechanisms of resistance to immune checkpoint blockade. EJC Skin Cancer, 4, 100800. https://doi.org/10.1016/j.ejcskn.2026.100800
Vancouver
Robert C, Bommareddy P, Wise-Draper T, Sacco J, In G, Couselo EM, et al. Biomarker and updated clinical data for RP1 plus nivolumab in anti–PD-1–failed melanoma from the IGNYTE trial demonstrate reversal of mechanisms of resistance to immune checkpoint blockade. EJC Skin Cancer. 2026;4:100800. doi:10.1016/j.ejcskn.2026.100800
BibTeX
@article{Robert2026,
author = {Robert, C. and Bommareddy, P.K. and Wise-Draper, T.M. and Sacco, J.J. and In, G.K. and Couselo, E. Muñoz and Schadendorf, D. and Niu, J. and Beasley, G.M. and Chmielowski, B. and Milhem, M.M. and Bowles, T.L. and Tsai, K.K. and Lebbé, C. and Gaudy-Marqueste, C. and Samson, A. and Zhu, J. and Viana, M. and Tucci, C. and Paratala, B. and Hou, J.W. and Wong, M.K.},
title = {Biomarker and updated clinical data for RP1 plus nivolumab in anti–PD-1–failed melanoma from the IGNYTE trial demonstrate reversal of mechanisms of resistance to immune checkpoint blockade},
journal = {EJC Skin Cancer},
year = {2026},
volume = {4},
pages = {100800},
doi = {10.1016/j.ejcskn.2026.100800}
}
EUVIMED